The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2019
Filed:
Apr. 07, 2016
Applicant:
LI Fu, Dalian, CN;
Inventors:
Li Fu, Dalian, CN;
Hongyu Fan, Dalian, CN;
Renwu Jiang, Dalian, CN;
Yu Zhang, Dalian, CN;
Kaiqian Wang, Dalian, CN;
Zhengxian Liu, Dalian, CN;
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); C07H 15/26 (2006.01); C07H 1/08 (2006.01); A61P 31/16 (2006.01); A61P 29/00 (2006.01); A61K 31/7034 (2006.01); A61K 31/7028 (2006.01);
U.S. Cl.
CPC ...
C07H 15/26 (2013.01); A61P 29/00 (2018.01); A61P 31/16 (2018.01); C07H 1/08 (2013.01); A61K 31/70 (2013.01); A61K 31/7028 (2013.01); A61K 31/7034 (2013.01);
Abstract
The present invention provides a novel phillygenin glucuronic acid derivative shown as a general formula (I). wherein, R=H, R=CH, R=CHor R=CH, R=CH,R=H or R-R=—CH—, R=CH; n=1-30. The present invention further relates to a preparation method of the compound, a pharmaceutical composition taking the compound as an active ingredient, as well as application of the compound in the present invention in antiviral diseases.